1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
- Donev_Sopharma_EN_Sell_20122023.pdf Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 247 | / | 2023 | ||||||||
Date of issue: | 2023-12-21 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023 | |||||||||||
Official market - legal basis | |||||||||||
art. 56. 1. 2 of Act on Public Offering. | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023 | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Donev_Sopharma_EN_Sell_20122023.pdf Donev_Sopharma_EN_Sell_20122023.pdf | Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023 |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2023-12-21 | Ognian Donev | Executive director |